Hildebrandt, M.G.; Lauridsen, J.F.; Vogsen, M.; Holm, J.; Vilstrup, M.H.; Braad, P.-E.; Gerke, O.; Thomassen, M.; Ewertz, M.; Høilund-Carlsen, P.F.;
et al. FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond. Cancers 2019, 11, 1190.
https://doi.org/10.3390/cancers11081190
AMA Style
Hildebrandt MG, Lauridsen JF, Vogsen M, Holm J, Vilstrup MH, Braad P-E, Gerke O, Thomassen M, Ewertz M, Høilund-Carlsen PF,
et al. FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond. Cancers. 2019; 11(8):1190.
https://doi.org/10.3390/cancers11081190
Chicago/Turabian Style
Hildebrandt, Malene Grubbe, Jeppe Faurholdt Lauridsen, Marianne Vogsen, Jorun Holm, Mie Holm Vilstrup, Poul-Erik Braad, Oke Gerke, Mads Thomassen, Marianne Ewertz, Poul Flemming Høilund-Carlsen,
and et al. 2019. "FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond" Cancers 11, no. 8: 1190.
https://doi.org/10.3390/cancers11081190
APA Style
Hildebrandt, M. G., Lauridsen, J. F., Vogsen, M., Holm, J., Vilstrup, M. H., Braad, P.-E., Gerke, O., Thomassen, M., Ewertz, M., Høilund-Carlsen, P. F., & The Centre for Personalized Response Monitoring in Oncology (PREMIO).
(2019). FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond. Cancers, 11(8), 1190.
https://doi.org/10.3390/cancers11081190